Devices & Diagnostics

SAE, PMA and other headache-inducing medtech acronyms (Best of MedCitizens)

Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who discuss life science current events on MedCityNews.com. Now here's the best of what YOU had to say:

Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who discuss life science current events on MedCityNews.com.

Now here’s the best of what YOU had to say:

Top 5 anxiety-provoking medtech acronyms. If you work for a big device company, you practically qualify as bilingual with the extent and array of acronyms forced into your personal lexicon. At one point I may have actually said a sentence like, “The CMO called the PI about the IRB process to estimate dates for FPI and CE mark in the PDP.”

presented by

Less Medicare spending: Skimping or smarter management? Yet Medicare spending slowed right along with the privately insured, suggesting something else was at work. Two of the nation’s leading health care experts clashed at a public forum on Tuesday over what might be behind the spending slowdown. The latest Medicare trustees report showed the program’s trust fund exhaustion date had remained almost unchanged in the past year despite less-than-anticipated tax collections due to the lingering effects of the recession.

Genomics is and will be a transformational megatrend in medical care, but the path to targeted drugs will be rocky at best. But “targeted” therapy is not always all that narrowly targeted in a way that either is effective for all nor is the drug necessarily side effect free ’ and it may be quite expensive. The story of Human Genome Sciences demonstrates that the path from a genomic discovery in the laboratory to a marketed drug can be long, expensive and fraught with many disappointments along the way. But conversely, innovation as demonstrated here is and will be the lifeblood of continued future success and improved human health.

Decision support and shared electronic data are 2 key tactics for ACOs. Of these five tactics, the biggest challenge is defining the care management rules – what conditions, wellness measures, home care interventions, best practices, and evidence should be incorporated into the point of care and analytic systems?

[Photo from graur razvan ionut]

presented by

Deanna Pogorelc is a Cleveland-based reporter who writes obsessively about life science startups across the country, looking to technology transfer offices, startup incubators and investment funds to see what’s next in healthcare. She has a bachelor’s degree in journalism from Ball State University and previously covered business and education for a northeast Indiana newspaper.

This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.